ArticleMayo Clinic proceedings2009
Targeting the pathogenic role of interleukin 1{beta} in the progression of smoldering/indolent myeloma to active disease.
Article in Mayo Clinic proceedings, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Pathological effects of SARS-CoV-2 on hematological and immunological cells: Alterations in count, morphology, and function.Pathology, research and practice · 2022Review
- Immune dysregulation and system pathology in COVID-19.Virulence · 2021Review
- Study of C-reactive protein, procalcitonin, and immunocyte ratios in 194 patients with sepsis.BMC emergency medicine · 2021Article
- Sepsis and Coronavirus Disease 2019: Common Features and Anti-Inflammatory Therapeutic Approaches.Critical care medicine · 2020Article
- A novel role for lidocaine in COVID-19 patients?British journal of anaesthesia · 2020Article
- Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression.Antioxidants (Basel, Switzerland) · 2020Review
- Targeting potential drivers of COVID-19: Neutrophil extracellular traps.The Journal of experimental medicine · 2020Article
- The Role of Interleukin 1β in the Pathogenesis of Lung Cancer.JTO clinical and research reports · 2020Review
- Article
- The ecology of cancer from an evolutionary game theory perspective.Interface focus · 2014Article
- Discovering the meaning of monoclonal gammopathy of undetermined significance: current knowledge, future challenges.Translational medicine @ UniSa · 2014Article
- Schnitzler's syndrome associated with pancreatitis: a disease of IL-1 dysregulation.Clinical rheumatology · 2012Article
- Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients.PloS one · 2011Article
- Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome.Case reports in genetics · 2011Article
- Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence.Mayo Clinic proceedings · 2010Review
- [IL-1 antagonists].Zeitschrift fur Rheumatologie · 2010Article
- Smoldering (asymptomatic) multiple myeloma: revisiting the clinical dilemma and looking into the future.Clinical lymphoma, myeloma & leukemia · 2010Review
- Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells.British journal of cancer · 2009Article
- Article
- Histone deacetylase inhibitors for treating a spectrum of diseases not related to cancer.Molecular medicine (Cambridge, Mass.)Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.